share_log

TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Sullivan Eric

SEC announcement ·  Jun 1, 2023 16:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more